in her position with therapsil, fearnley speaks with each patient and hears their stories about facing life-threatening illnesses and the fear and anxiety that accompanies a terminal diagnosis.
“through all of my work through doing that, i honestly never really thought about what if that was me?” she says. “what if i had a limited time left on this earth? what would that mean for me if i was in the shoes of the patients i care for?”
having now completed the 10-week, 100+ hour course, fearnley feels better equipped to do her job and feels more confident discussing the therapy with prospective patients.
“from my own perspective, it would be really weird if i was like, ‘oh, yeah, this is what’s going to happen, you’re going to feel this way.’ and if i have no experience whatsoever, they’d be like, ‘who are you to tell me that?’”
now when she discloses that she’s gone through the therapy herself, within a proper framework and container of safety, she says she feels a sense of ease from the patients.
“there’s a sense of trust and they’re just a little bit more relaxed,” she explains.
the course was designed by dave phillips, a registered clinical counsellor, and another one of the five exemption holders. along with developing the curriculum, phillips works with therapsil’s training director to recruit healthcare workers into the program.
“our contention is that doing the medicine yourself is not just interesting, but is requisite to safely hold space for people,” he says. “it’s an altered state. this isn’t a normal kind of therapy, right? it’s very, very different than anything any of the therapists would have been used to.”
in designing the course, phillips leaned on the research from institutions such as johns hopkins, imperial college and new york university. the phased approach includes preparatory therapy and building a relationship with the therapeutic team, the dosing session itself, and post-integration therapy.